Buprecare Multidose

1 x 10 ml
Liquid for injection, solution
IM
IV

Species

Dogs and cats

Indications

DOG

Post-operative analgesia.

Potentiation of the sedative effects of centrally-acting agents.

CAT

Post-operative analgesia.

Dose to be administered and administration route

Administration: Dog Intramuscular or intravenous injection

Cat Intramuscular or intravenous injection

Before administration, the weight of the animal should be accurately determined.

Species

Post-Operative Analgesia

Potentiation of Sedation

Dog

10–20 μg per kg (0.3–0.6 ml per 10 kg)

For further pain relief, repeat if necessary after 3–4 hours with 10 μg per kg or 5–6 hours with 20 μg per kg.

10–20 μg per kg (0.3–0.6 ml per 10 kg).

Cat

10–20 μg per kg (0.3–0.6 ml per 10 kg), repeated if necessary, once, after 1-2 hours.

-

While sedative effects are present by 15 minutes after administration, analgesic activity becomes apparent after approximately 30 minutes. To ensure that analgesia is present during surgery and immediately on recovery, the product should be administered pre-operatively as part of premedication.

When administered for potentiation of sedation or as part of premedication, the dose of other centrally-acting agents, such as acepromazine or medetomidine, should be reduced. The reduction will depend on the degree of sedation required, the individual animal, the type of other agents included in premedication and how anaesthesia is to be induced and maintained. It may also be possible to reduce the amount of inhalational anaesthetic used.

Animals administered opioids possessing sedative and analgesic properties may show variable responses. Therefore, the responses of individual animals should be monitored and subsequent doses should be adjusted accordingly. In some cases repeat doses may fail to provide additional analgesia. In these cases, consideration should be given to using a suitable injectable NSAID.

An appropriately graduated syringe must be used to allow accurate administration of the required dose volume. This is particularly important when injecting small volumes.

The vial seal may be punctured up to a maximum of 30 times.

Adverse reactions

Salivation, bradycardia, hypothermia, agitation, dehydration and miosis can occur in the dog, and rarely hypertension and tachycardia.

Mydriasis and signs of euphoria (excessive purring, pacing, rubbing) commonly occur in cats, and will usually resolve within 24 hours.

Buprenorphine may occasionally cause significant respiratory depression; refer to section 4.5.

When used to provide analgesia, sedation is rarely seen, but may occur at dose levels higher than those recommended.

Dispensing

POM-V - Prescription Only Medicine – Veterinarian
Cat
Dog
PRICE Only for registered vets. Create a free profile to access all features.. Login
Art. Nr. 32742/4025
EAN 5055037401547
PACKAGES
Buprecare Multidose
Animalcare Ltd
1 x 10 ml
32742/4025

Similar products

Showing 7 of 7 results
Only for registered vets. Create a free profile to access all features. Login
Cat
Dog

Buprecare Multidose

0,3 mg/ml Liquid for injection, solution
1 x 10 ml
Cat
Dog

Buprecare Multidose

0,3 mg/ml Liquid for injection, solution
1 x 10 ml
Cat
Dog

Buprecare Multidose

0,3 mg/ml Liquid for injection, solution
1 x 10 ml
Cat
Dog

Buprecare Multidose

0,3 mg/ml Liquid for injection, solution
1 x 10 ml
Cat
Dog

Buprecare Multidose

0,3 mg/ml Liquid for injection, solution
1 x 10 ml
Cat
Dog

Buprecare Multidose

0,3 mg/ml Liquid for injection, solution
1 x 10 ml
Cat
Dog

Buprecare Multidose

0,3 mg/ml Liquid for injection, solution
1 x 10 ml
VETiSearch ApS - C.F. Richs Vej 99D - 2000 Copenhagen - Denmark - contact@vetisearch.co.uk - Legal registration number: 39926679
VETiSearch.co.uk Copyright © 2025 . All rights reserved. This information is intended only for residents of Great Britain. The product information provided on this site is intended only for residents of Great Britain. Products may have different product information in different countries.